Immunome Inc. (NASDAQ: IMNM) reported a wider net loss of $53.8 million in Q1 2026, compared to $41.6 million in Q1 2025, primarily due to increased r...
The article notes that Immunome (IMNM) stock increased by 13.3%. It poses the question of whether this upward trend will continue, suggesting an analy...
Neutral
Nan Fung Trinity HK Ltd. increased its holdings in Immunome, Inc. (NASDAQ:IMNM – Free Report) by 20.7% during the 4th quarter, Holdings Channel.com re...